FULC
Closed
Fulcrum Therapeutics Inc
6.84
-0.04 (-0.58%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 6.88
Day's Range: 6.155 - 6.91
Send
sign up or login to leave a comment!
When Written:
2.805
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company that focuses on developing small molecule therapies to treat genetically defined diseases. The company's proprietary product platform leverages insights into gene regulation and epigenetics to identify and develop potential therapies for rare genetic diseases. Fulcrum's lead product candidate, losmapimod, is being developed for the treatment of facioscapulohumeral muscular dystrophy (FSHD), a rare genetic disease that causes progressive muscle weakness and wasting. The company is also developing other product candidates for the treatment of other rare genetic diseases. Fulcrum Therapeutics Inc was founded in 2016 and is headquartered in Cambridge, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








